Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 7Other hematologic neoplasm 2Lymphoid 2CNS 2Thoracic 1Plasma cell 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Carcinoma, Ovarian Epithelial 3Ovarian Neoplasms 2Endometrial Neoplasms 2Sarcoma, Endometrial Stromal 1Sarcoma 1Recurrent Uterine Corpus Sarcoma 1Fallopian Tube Neoplasms 1

Interventions

Filgrastim 15Carboplatin 10Ifosfamide 9Doxorubicin 9Cyclophosphamide 9Peripheral Blood Stem Cell Transplantation 7pembrolizumab 6Radiotherapy 6Gemcitabine 6Temozolomide 5Etoposide 5Cisplatin 5Paclitaxel 4Docetaxel 4Amifostine 4aldesleukin 3aflibercept 3Trastuzumab 3Specimen Handling 3Radiosurgery 3Psychiatric Rehabilitation 3Magnetic Resonance Spectroscopy 3Biopsy 3tislelizumab 2sodium thiosulfate 2selinexor 2pazopanib 2palbociclib 2etoposide phosphate 2eribulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Thalidomide × Gynecologic × Clear all
NCT00006005 2013-06-21

Thalidomide in Treating Patients With Gynecologic Sarcomas

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Sarcoma, Endometrial Neoplasms, Sarcoma, Endometrial Stromal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡